Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Mar. 31, 2014
Mar. 31, 2013
Current assets:    
Cash $ 2,665 $ 64,607
Accounts receivable 166,404 15,110
Inventory 57,965 7,573
Deferred financing cost 54,288 0
Total current assets 281,322 87,290
Fixed assets, net 286,986 38,083
Equipment deposits - related party 0 15,000
Total assets 568,308 140,373
Current liabilities:    
Accounts payable 320,154 12,651
Accounts payable - related party 18,403 490
Accrued expenses 56,601 5,400
Accrued interest 19,829 1,315
Revolving financing 83,348 0
Notes payable 0 150,000
Derivative liability 337,988 0
Total current liabilities 836,323 169,856
Redeemable convertible Preferred stock 83,820 0
Stockholders' deficit:    
Preferred stock - $0.001 par value, 100,000,000 shares authorized. Series A issued 20,000,000 20,000 0
Common stock, Class A, $0.001 par value, 1,125,000,000 shares authorized, 81,602,175 and 77,500,000 shares issued and outstanding as of March 31, 2014 and March 31, 2013, respectively 81,602 77,500
Additional paid in capital 4,059,464 176,405
Common stock issuable 0 0
Deficit accumulated during development stage (4,512,901) (283,388)
Total stockholders' deficit (351,835) (29,483)
Total liabilities and stockholders' deficit $ 568,308 $ 140,373